The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

The Sackler family and Purdue Pharma have agreed to pay $7.4 billion to resolve nationwide opioid litigation, marking a major ...

Members of the family who own OxyContin maker Purdue Pharma ... The deal, agreed to by Purdue Pharma, the Sackler family ...

State AGs have reached a new opioid settlement worth $7.4 billion with Purdue Pharma and its owners. The settlement does not ...

Pennsylvania stands to receive up to $212 million paid out by the family and company behind the nationwide saturation of ...

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...

Members of the family who own OxyContin maker Purdue Pharma ... agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

Bankrupt Purdue Pharma LP and members of the billionaire Sackler family agreed to pay $7.4 billion to a group of US states, ...

“The Sackler family relentlessly pursued profit at the ... Purdue Pharma introduced 10mg prescriptions of OxyContin in 1996 and marketed it as a nonaddictive drug to treat daily pain.

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...